These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 34490243)

  • 21. Paracrine Activation of Chemokine Receptor CCR9 Enhances The Invasiveness of Pancreatic Cancer Cells.
    Heinrich EL; Arrington AK; Ko ME; Luu C; Lee W; Lu J; Kim J
    Cancer Microenviron; 2013 Dec; 6(3):241-5. PubMed ID: 23371851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of the CCL25-CCR9 axis in beta-cell function: potential for therapeutic intervention in type 2 diabetes.
    Atanes P; Lee V; Huang GC; Persaud SJ
    Metabolism; 2020 Dec; 113():154394. PubMed ID: 33058852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CCL25/CCR9 interaction promotes the malignant behavior of salivary adenoid cystic carcinoma
    Chai S; Wen Z; Zhang R; Bai Y; Liu J; Li J; Kongling W; Chen W; Wang F; Gao L
    PeerJ; 2022; 10():e13844. PubMed ID: 36003306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired accumulation of antigen-specific CD8 lymphocytes in chemokine CCL25-deficient intestinal epithelium and lamina propria.
    Wurbel MA; Malissen M; Guy-Grand D; Malissen B; Campbell JJ
    J Immunol; 2007 Jun; 178(12):7598-606. PubMed ID: 17548595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCR9 mediates PI3K/AKT-dependent antiapoptotic signals in prostate cancer cells and inhibition of CCR9-CCL25 interaction enhances the cytotoxic effects of etoposide.
    Sharma PK; Singh R; Novakovic KR; Eaton JW; Grizzle WE; Singh S
    Int J Cancer; 2010 Nov; 127(9):2020-30. PubMed ID: 20127861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C-C motif chemokine receptor 9 regulates obesity-induced insulin resistance via inflammation of the small intestine in mice.
    Amiya T; Nakamoto N; Irie J; Taniki N; Chu PS; Koda Y; Miyamoto K; Yamaguchi A; Shiba S; Morikawa R; Itoh H; Kanai T
    Diabetologia; 2021 Mar; 64(3):603-617. PubMed ID: 33399911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased CCL25 and T Helper Cells Expressing CCR9 in the Salivary Glands of Patients With Primary Sjögren's Syndrome: Potential New Axis in Lymphoid Neogenesis.
    Blokland SLM; Hillen MR; Kruize AA; Meller S; Homey B; Smithson GM; Radstake TRDJ; van Roon JAG
    Arthritis Rheumatol; 2017 Oct; 69(10):2038-2051. PubMed ID: 28622456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased circulating CXCR3 + CCR9+T helper cells are associated with elevated levels of their ligands CXCL10 and CCL25 in the salivary gland of patients with Sjögren's syndrome to facilitate their concerted migration.
    Blokland SLM; Kislat A; Homey B; Smithson GM; Kruize AA; Radstake TRDJ; van Roon JAG
    Scand J Immunol; 2020 Mar; 91(3):e12852. PubMed ID: 31733111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CCR9-CCL25 interaction suppresses apoptosis of lung cancer cells by activating the PI3K/Akt pathway.
    Li B; Wang Z; Zhong Y; Lan J; Li X; Lin H
    Med Oncol; 2015 Mar; 32(3):66. PubMed ID: 25691296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mice lacking the CCR9 CC-chemokine receptor show a mild impairment of early T- and B-cell development and a reduction in T-cell receptor gammadelta(+) gut intraepithelial lymphocytes.
    Wurbel MA; Malissen M; Guy-Grand D; Meffre E; Nussenzweig MC; Richelme M; Carrier A; Malissen B
    Blood; 2001 Nov; 98(9):2626-32. PubMed ID: 11675330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-CCL25 antibody prolongs skin allograft survival by blocking CCR9 expression and impairing splenic T-cell function.
    Li J; Xiong T; Xiao R; Xiong A; Chen J; Altaf E; Zheng Y; Zhu G; He Y; Tan J
    Arch Immunol Ther Exp (Warsz); 2013 Jun; 61(3):237-44. PubMed ID: 23456208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion.
    Johnson EL; Singh R; Singh S; Johnson-Holiday CM; Grizzle WE; Partridge EE; Lillard JW
    World J Surg Oncol; 2010 Jul; 8():62. PubMed ID: 20649989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toll-Like Receptor 4 Promotes Th17 Lymphocyte Infiltration Via CCL25/CCR9 in Pathogenesis of Experimental Autoimmune Encephalomyelitis.
    Zhang Y; Han J; Wu M; Xu L; Wang Y; Yuan W; Hua F; Fan H; Dong F; Qu X; Yao R
    J Neuroimmune Pharmacol; 2019 Sep; 14(3):493-502. PubMed ID: 31065973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin-converting enzyme inhibition down-regulates the pro-atherogenic chemokine receptor 9 (CCR9)-chemokine ligand 25 (CCL25) axis.
    Abd Alla J; Langer A; Elzahwy SS; Arman-Kalcek G; Streichert T; Quitterer U
    J Biol Chem; 2010 Jul; 285(30):23496-505. PubMed ID: 20504763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CCR9 Antagonists in the Treatment of Ulcerative Colitis.
    Bekker P; Ebsworth K; Walters MJ; Berahovich RD; Ertl LS; Charvat TT; Punna S; Powers JP; Campbell JJ; Sullivan TJ; Jaen JC; Schall TJ
    Mediators Inflamm; 2015; 2015():628340. PubMed ID: 26457007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The chemokine receptor CCR9 is required for the T-cell-mediated regulation of chronic ileitis in mice.
    Wermers JD; McNamee EN; Wurbel MA; Jedlicka P; Rivera-Nieves J
    Gastroenterology; 2011 May; 140(5):1526-35.e3. PubMed ID: 21300065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucocorticoids Suppress CCR9-Mediated Chemotaxis, Calcium Flux, and Adhesion to MAdCAM-1 in Human T Cells.
    Wendt E; White GE; Ferry H; Huhn M; Greaves DR; Keshav S
    J Immunol; 2016 May; 196(9):3910-9. PubMed ID: 27016601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mesenchymal stem cells and their chondrogenic differentiated and dedifferentiated progeny express chemokine receptor CCR9 and chemotactically migrate toward CCL25 or serum.
    Ullah M; Eucker J; Sittinger M; Ringe J
    Stem Cell Res Ther; 2013 Aug; 4(4):99. PubMed ID: 23958031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Role of inflammatory macrophages and CCR9/CCL25 chemokine axis in the pathogenesis of liver injury as a therapeutic target].
    Nakamoto N
    Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(5):460-467. PubMed ID: 27795503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CCR9 signaling in dendritic cells drives the differentiation of Foxp3
    Pathak M; Padghan P; Halder N; Shilpi ; Kulkarni N; Sonar SA; Lal G
    Eur J Immunol; 2020 Mar; 50(3):404-417. PubMed ID: 31755547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.